Related Experiment Video
Updated: Aug 14, 2026

Functional Neuroimaging Using Ultrasonic Blood-brain Barrier Disruption and Manganese-enhanced MRI
Published on: July 12, 2012
Manganese neurotoxicity: connecting the dots along the continuum of dysfunction
1Institute of Occupational and Environmental Health, Department of Community Medicine, School of Medicine, West Virginia University, P.O. Box 9190, 3801 Health Sciences Center South, Morgantown, WV 26506-9190, United States. cmartin@hsc.wvu.edu
Abstract:
Three different manifestations of manganese neurotoxicity have been described. The first, and historically most prominent, is often termed manganism: a dramatic extrapyramidal syndrome following acute, overwhelming exposure. While resembling Idiopathic Parkinson's Disease (IPD), most authorities have regarded the two conditions as clinically and pathophysiologically distinct. The second manifestation, reported by several investigators starting in the 1980s, consisted of subclinical and subfunctional declines in the performance of specialized neuropsychological tests. The implication of these cross-sectional findings was that, when superimposed upon age-related attritional effects, increased rates of clinical disease could result. In this decade, it has been proposed that manganese exposure may play a role in the development of IPD itself. Investigating the relationship between these three manifestations should be a priority for future research.
Insights
Manganese exposure can cause neurotoxicity, leading to manganism, subclinical declines, and potentially contributing to Idiopathic Parkinson's Disease (IPD). Further research is needed to understand these manganese-related neurological effects.
Area of Science:
- Neuroscience
- Toxicology
- Environmental Health
Background:
- Manganese neurotoxicity presents in distinct forms.
- Historically, manganism (an extrapyramidal syndrome) was recognized after acute, high-level exposure.
- Manganism is often considered distinct from Idiopathic Parkinson's Disease (IPD).
Purpose of the Study:
- To review the three described manifestations of manganese neurotoxicity.
- To discuss the potential role of manganese in the development of IPD.
- To highlight the need for research into the relationship between these manifestations.
Main Methods:
- Literature review and synthesis of existing research on manganese neurotoxicity.
- Comparison of clinical and pathophysiological features of manganism and IPD.
- Analysis of neuropsychological findings related to manganese exposure.
Main Results:
- Three key manifestations of manganese neurotoxicity are identified: manganism, subclinical neuropsychological deficits, and a potential role in IPD.
- Subclinical declines suggest that manganese exposure may exacerbate age-related neurological changes.
- Emerging evidence suggests manganese exposure may contribute to the development of IPD.
Conclusions:
- Understanding the spectrum of manganese neurotoxicity is crucial.
- Further investigation is required to elucidate the link between manganese exposure and IPD.
- Research priorities should focus on the relationship between the different manganese-induced neurological conditions.
More Related Videos
Related Concept Videos
Hepatic Encephalopathy
Parkinson Disease ll: Pathophysiology
Multiple Sclerosis l: Introduction
Secondary Spinal Cord Injury llI: Pathophysiology
Dementia l: Introduction
Neural Regulation

